Sheng Yao

Title: Innovations and Contributions of Inventor Sheng Yao

Introduction

Sheng Yao is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of five patents to his name, his work has the potential to impact the treatment of various immune dysfunction diseases.

Latest Patents

One of Sheng Yao's latest patents is the "Anti-IL-17A antibody and use thereof." This invention provides an antibody that specifically binds to IL-17A with high affinity. It also includes a nucleic acid molecule encoding the antibody, an expression vector, and a host cell for expressing the antibody. Additionally, it outlines a method for preparing the antibody and a pharmaceutical composition for treating immune dysfunction diseases. Another notable patent is the "Anti-BTLA antibody," which relates to an anti-BTLA antibody or an antigen-binding fragment. This invention includes specific light and heavy chain CDR domains and also covers the nucleic acid molecule encoding the antibody, its expression vector, and therapeutic uses.

Career Highlights

Sheng Yao has worked with notable companies in the biotechnology sector, including Shanghai Junshi Biosciences Co., Ltd. and Suzhou Junmeng Biosciences Co., Ltd. His experience in these organizations has allowed him to advance his research and development efforts in antibody therapies.

Collaborations

Sheng Yao has collaborated with several professionals in his field, including Jian Yao and Hui Feng. These collaborations have likely contributed to the success of his innovative projects and patents.

Conclusion

Sheng Yao's work in developing therapeutic antibodies showcases his commitment to advancing medical science. His patents reflect significant innovations that could lead to improved treatments for immune dysfunction diseases.